Alcohol dependence: the impact of cognitive behaviour therapy with or without naltrexone on subjective health status [PDF]
, 2004 Objectives: To examine the health-related quality of life of alcohol-dependent patients across a 12-week cognitive behaviour treatment (CBT) program and identify whether the patient selection of the anticraving medication naltrexone further enhanced ...
Tucker, J +14 more
core +1 more source
Perioperative naltrexone management: a scoping review by the perioperative pain and addiction interdisciplinary network. [PDF]
Substance use disorders, including alcohol use disorder, are a public health concern that affect more than 150 million people globally. The opioid antagonist naltrexone is being increasingly prescribed to treat opioid use disorder, alcohol use disorder ...
Wu, Mia +7 more
core +1 more source
Naltrexone implant for opioid use disorder. [PDF]
, 2021 The continued rise in the availability of illicit opioids and opioid-related deaths in the United States has left physicians, researchers, and lawmakers desperate for solutions to this ongoing epidemic.
Orellana, Claudia V +31 more
core +2 more sources
A Narrative Review on Bio-Physiology of Naltrexone Treatment in Pornography Addiction [PDF]
Problematic pornography use remains a debatable entity, with features overlapping behavioral addictions and impulse control disorders. The controversial nosological status also provides challenges in formulating management plans as there exists no proven
Manoj Kumar Sharma +2 more
core +1 more source
Evaluation of a prison-based naltrexone program [PDF]
, 2007 The study evaluated the introduction of naltrexone in an Australian prison system for imprisoned male heroin users. Treatment outcomes were analysed for two sub‐samples taken from an unsuccessful randomised controlled trial. The first sample comprised 68
Dolan, Kate A. +2 more
core +1 more source
Bupropion and Naltrexone in Methamphetamine Use Disorder [PDF]
, 2021 BACKGROUND: The use of naltrexone plus bupropion to treat methamphetamine use disorder has not been well studied. METHODS: We conducted this multisite, double-blind, two-stage, placebo-controlled trial with the use of a sequential parallel comparison ...
Bart, Gavin +19 more
core +1 more source
Free naltrexone levels in dams and offspring with naltrexone implant. [PDF]
, 2013 Temporal profiles of free naltrexone concentration are shown in offspring blood or amniotic fluid (A, cohort 1) or maternal blood (A and B, cohorts 1, 2 & 3.) after maternal administration with a naltrexone implant (25 mg, s.c.).
Robert J. Tait (292446) +5 more
core +1 more source
Naltrexone HCI/bupropion HCI for chronic weight management in obese adults: patient selection and perspectives [PDF]
, 2016 Cenk Tek Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA Abstract: Naltrexone, an opiate antagonist, and bupropion, a noradrenergic/dopaminergic antidepressant, have many effects on the reward systems of the brain.
Tek C
core
Achieving long-term continuous blood naltrexone and 6-β-naltrexol coverage following sequential naltrexone implants [PDF]
, 2004 The aim of this study was to assess blood free naltrexone and 6-β-naltrexol levels with time following treatment with sequential sustained-release naltrexone preparations. Data were collected from blood samples analysed independently for naltrexone and 6-
Hansson, Robert C +5 more
core +1 more source
Letter to the editor: naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date [PDF]
, 2015 Anna M Buehler Hospital Alemao Oswaldo Cruz, Institute of Health Education and Sciences, Sao Paulo, BrazilI read with great interest the systematic review by Caixàs et al1 on the effect of naltrexone sustained-release/bupropion sustained-release (
Buehler AM
core